Cargando…
Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
Autores principales: | Torres-Bayona, Sergio, Aldaz, Paula, Auzmendi-Iriarte, Jaione, Saenz-Antoñanzas, Ander, Garcia, Idoia, Arrazola, Mariano, Gerovska, Daniela, Undabeitia, Jose, Querejeta, Arrate, Egaña, Larraitz, Villanúa, Jorge, Ruiz, Irune, Sarasqueta, Cristina, Urculo, Enrique, Araúzo-Bravo, Marcos J., Huarte, Maite, Samprón, Nicolas, Matheu, Ander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209411/ https://www.ncbi.nlm.nih.gov/pubmed/35725740 http://dx.doi.org/10.1038/s41598-022-13824-8 |
Ejemplares similares
-
PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
por: Torres-Bayona, Sergio, et al.
Publicado: (2018) -
Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
por: Egaña, Larraitz, et al.
Publicado: (2020) -
Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2019) -
Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
por: Garros-Regulez, Laura, et al.
Publicado: (2016) -
Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2020)